Pioglitazone Therapy in Patients With Stroke and Prediabetes
This post hoc analysis of Insulin Resistance Intervention After Stroke (IRIS) randomized clinical trial assesses the association of pioglitazone vs placebo with recurrent stroke, myocardial infarction, and other cardiovascular events.
Source: JAMA Neurology - Category: Neurology Source Type: research
More News: Actos | Brain | Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Attack | Insulin | Neurology | Stroke